These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28830)

  • 1. Reports from the Workshop on the Use of Steroids as Carriers of Cytotoxic Agents in Breast Cancer: Cancer Therapy Evaluation Program, Division of Cancer Treatment, National Cancer Institute.
    Cancer Treat Rep; 1978 Aug; 62(8):1239. PubMed ID: 28830
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant chemotherapy of breast cancer. Sponsored by the National Cancer Institute, assisted by the Office for Medical Applications of Research, NIH.
    Conn Med; 1980 Nov; 44(11):721-3. PubMed ID: 7226778
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trials: a recent emphasis in the prevention program of the National Cancer Institute.
    DeWys WD; Greenwald P
    Semin Oncol; 1983 Sep; 10(3):360-4. PubMed ID: 6665563
    [No Abstract]   [Full Text] [Related]  

  • 4. NIH Consensus Development Conference summary: Adjuvant Chemotherapy of Breast Cancer.
    J Tenn Med Assoc; 1981 Mar; 74(3):190-2. PubMed ID: 7024644
    [No Abstract]   [Full Text] [Related]  

  • 5. NIH consensus-development statement. Adjuvant chemotherapy of breast cancer. The NIH Consensus-Development Panel.
    N Engl J Med; 1980 Oct; 303(14):831-2. PubMed ID: 6997737
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy in women with breast cancer.
    Liebmann J; Haskins C; McAneny B; Giudice R; Clark D; Marshall N
    Ann Intern Med; 2003 Nov; 139(10):867-8; author reply 868-9; discussion 869. PubMed ID: 14623631
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy in women with breast cancer.
    Harlan LC; Clegg LX; Warren JL
    Ann Intern Med; 2003 Nov; 139(10):868; author reply 868-9. PubMed ID: 14623632
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy for breast cancer.
    Sarg MJ
    J Reprod Med; 1979 Jul; 23(1):3-11. PubMed ID: 226698
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant chemotherapy of breast cancer.
    Check WA
    JAMA; 1980 Sep; 244(10):1079, 1083-4. PubMed ID: 6106073
    [No Abstract]   [Full Text] [Related]  

  • 10. NCI launches an innovative design for a breast cancer clinical trial.
    Whitworth A
    J Natl Cancer Inst; 2006 Sep; 98(17):1178-9. PubMed ID: 16954467
    [No Abstract]   [Full Text] [Related]  

  • 11. Planning combined therapy--the interaction of experimental and clinical studies.
    Carter SK
    Cancer Chemother Rep 2; 1974 Mar; 4(1):3-11. PubMed ID: 4826498
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mammography. A conference on screening for carcinoma of the breast held by the National Institute of Health and the National Cancer Institute (author's transl)].
    Rofo; 1978 Sep; 129(3):368-70. PubMed ID: 28999
    [No Abstract]   [Full Text] [Related]  

  • 13. Promising new agents under development by the Division of Cancer Treatment, Diagnosis, and Centers of the National Cancer Institute.
    Christian MC; Pluda JM; Ho PT; Arbuck SG; Murgo AJ; Sausville EA
    Semin Oncol; 1997 Apr; 24(2):219-40. PubMed ID: 9129691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The National Cancer Institute: cancer drug discovery and development program.
    Grever MR; Schepartz SA; Chabner BA
    Semin Oncol; 1992 Dec; 19(6):622-38. PubMed ID: 1462164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress report on the screening program at the Division of Cancer Treatment, National Cancer Institute.
    Goldin A; Venditti JM
    Cancer Treat Rev; 1980 Dec; 7(4):167-76. PubMed ID: 7214373
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings of the NCI-EORTC symposium on new drugs in cancer therapy, Institut Jules Bordet, September 7--8, 1978 Brussels, Belgium.
    Cancer Treat Rep; 1979 May; 63(5):807-936. PubMed ID: 36983
    [No Abstract]   [Full Text] [Related]  

  • 17. Report of the Cancer Chemotherapy Collaborative Program Review Committee: the Richardson report. June 1966, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
    Cancer Treat Rep; 1984 Jan; 68(1):343-56. PubMed ID: 6692435
    [No Abstract]   [Full Text] [Related]  

  • 18. Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.
    Gralow JR; Burstein HJ; Wood W; Hortobagyi GN; Gianni L; von Minckwitz G; Buzdar AU; Smith IE; Symmans WF; Singh B; Winer EP
    J Clin Oncol; 2008 Feb; 26(5):814-9. PubMed ID: 18258991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening at the National Cancer Institute.
    Goldin A; Venditti JM; Carter SK
    Natl Cancer Inst Monogr; 1977 Mar; (45):37-48. PubMed ID: 337155
    [No Abstract]   [Full Text] [Related]  

  • 20. Problems in the development of cytotoxic moieties linked to hormones.
    Lippman ME; Heuson JC; Muggia FM
    Cancer Treat Rep; 1978 Aug; 62(8):1267-8. PubMed ID: 688270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.